|
Richard Haupt, MD, Vice President, Medical Development Scientific & Clinical Affairs, at Pfizer where he serves as the global franchise lead for pipeline vaccines and Kathrin U. Jansen, PhD, Senior Vice President and head of Vaccine Research and Development at Pfizer Inc and Chris Webber, MD, Senior Director, Vaccines Clinical Research and Development. Dr. Webber is clinical program lead of the recently acquired meningococcal ACWY program from GSK, and is the clinical program lead for Pfizer’s Clostridium difficile vaccine. Our discussion will be focused on C. difficile Prevention: Evaluating
|
